HLA-DR17
title: "HLA-DR17" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["hla-dr-haplotypes"] topic_path: "general/hla-dr-haplotypes" source: "https://en.wikipedia.org/wiki/HLA-DR17" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
HLA-DR17 (DR17) is an HLA-DR serotype that recognizes the DRB1*0301 and *0304 gene products. DR17 is found at high frequency in Western Europe (such as Western Ireland, N. Spain, Sardinia). DR17 is part of the broader antigen group HLA-DR3 and is very similar to the group HLA-DR18.
Serology
DR17 recognizes the DRB1*0301, *0304 alleles.
Disease associations
By serotype
DR17 is associated with non-chronic sarcoidosis, infantile spasm/epilepsy, rabies vaccine-induced autoimmune encephalomyelitis and cardiovascular hypertrophy in subjects with arterial hypertension People with DR17 show a tendency toward benzylpenicilloyl allergies.
By allele
DRB1*0301: diabetes mellitus type 1, myositis, early onset Graves disease, type 1 autoimmune hepatitis, inflammatory inclusion body myositis. In autoimmune hepatitis, DRB1*0301 correlates with more severe and difficult to treat disease.
By haplotype
DRB10301:DQA105:DQB1*0201 is associated with diabetes mellitus type 1, ovarian cancer, non-thymomic myasthenia gravis, idiopathic inflammatory myopathies, non-cancer associated Lambert-Eaton myasthenic syndrome and sarcoidosis
By phenotype
The DRB10301/DRB11501 heterozygote is linked to primary Sjögren's syndrome
Genetic Linkage
::data[format=table] | DRA | DRB1 | DRB3 | DQA1 | DQB1 | DRB1 || | Serotypes | HLA-A | HLA C | HLA B | DRB1 | |---|---|---|---|---|---|---|---|---|---|---| | Serotypes | | | | | | | | | | | | DR17 | *0101 | *0301 | 0101 | | | | | | | | | *0101 | *0301 | 0201 | | | | | | | | | | Serotypes | | | | | | | | | | | | DR17(3)-DQ2(2.5) | *0501 | *0201 | *0301 | | | | | | | | | A1-Cw7-B8-DR17(3) | *0101 | *0701 | *0801 | *0301 | | | | | | | | A2-Cw7-B8-DR17(3) | *0201 | *0701 | *0801 | *0301 | | | | | | | | A30-Cw5-B18-DR17(3) | *3002 | *0501 | *1801 | *0301 | | | | | | | ::
HLA-DR17 is genetically linked to DR52 and HLA-DQ2 serotypes. These serotypes are the result of gene products from the HLA-DRB3* and HLA DQA10501 and HLA DQB10201 alleles. DRB1*0301 is frequently within by the "Super-B8" or ancestral HLA haplotype:
A0101 : Cw0701 : B0801 : DRB10301 : DQA10501 : DQB10201
This haplotype is known as "Super B8", "European ancestral haplotype", or "AH8.1"
References
References
- [http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]
- (1997). "HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.". Am J Respir Crit Care Med.
- (2003). "T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis.". Sarcoidosis Vasc Diffuse Lung Dis.
- (2001). "Contribution of the MHC class II antigens to the etiology of infantile spasm in Mexican Mestizos.". Epilepsia.
- (1999). "Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis.". Ann Neurol.
- (2001). "Association of specific HLA phenotypes with left ventricular mass and carotid intima-media thickness in hypertensives.". Am J Hypertens.
- (2006). "HLA-DRB genotype and specific IgE responses in patients with allergies to penicillins". Chin. Med. J..
- (2006). "HLA class II allele frequencies in type 1A diabetes mellitus Slovak patients.". Bratisl Lek Listy.
- (2006). "Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.". Medicine (Baltimore).
- (1997). "HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB10701,DQA10201 haplotype.". Tissue Antigens.
- (1997). "Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.". Hepatology.
- (1997). "An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families". Brain.
- (2007). "Current therapy for autoimmune hepatitis". Nature Clinical Practice Gastroenterology & Hepatology.
- (2006). "Is the Association Between TNF-α-308 A Allele and DMT1 Independent of HLA-DRB1, DQB1 Alleles?". Mediators Inflamm.
- (2006). "HLA-class II haplotype associations with ovarian cancer". Int J Cancer.
- (1999). "Correlation of thymic pathology with HLA in myasthenia gravis". Clinical Immunology.
- (2000). "Update on the genetics of the idiopathic inflammatory myopathies". Curr Opin Rheumatol.
- (2000). "Increased frequency of HLA class II alleles DRB10301 and DQB10201 in Lambert-Eaton myasthenic syndrome without associated cancer". Hum Immunol.
- (2007). "HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, −DRB10301, and −DQB10201 haplotype in clinical variations of the disease". Tissue Antigens.
- (1998). "DRB115 and DRB103 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility". Clin Exp Rheumatol.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::